Validation of post‐treatment PET‐based dosimetry software for hepatic radioembolization of Yttrium‐90 microspheres

201933 citationsJournal Article

Authors

Nichole M. Maughan · Washington University in St. Louis

José Garcia-Ramirez · Washington University in St. Louis

Matt Arpidone · RHAMM Technologies (United States)

Amy Swallen · RHAMM Technologies (United States)

Richard Laforest · Washington University in St. Louis

S Goddu · Washington University in St. Louis

Parag J. Parikh

Abstract

Dose calculation results from MIM SurePlan were found to be in good agreement with our in-house algorithm. This indicates that MIM SurePlan performs as it should and, hence, can be deemed accepted and commissioned for clinical use for post-implant PET-based dosimetry of <sup>90</sup> Y radioembolization.

Topics & Keywords

Advanced Radiotherapy Techniques Hepatocellular Carcinoma Treatment and Prognosis Radiopharmaceutical Chemistry and Applications

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Medical Physics

Volume 46, Issue 5, pp. 2394-2402

DOI: 10.1002/mp.13444

Field-Weighted Citation Impact: 4.81